EDDC Archives - dotlah!

Everest Medicines To Develop, Commercialize EDDC’s Small Molecules As Potential COVID-19 Oral Antiviral Treatments

January 24, 2022

Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), and Singapore’s Experimental Drug Development Centre (“EDDC”) today announced a global licensing agreement under which Everest will obtain exclusive worldwide rights to develop,…

View Post

View Post

EDDC And NTU Develop Novel Drug Candidates To Combat Deadly, Ancient Disease

August 27, 2021

Tuberculosis is caused by the M. tuberculosis bacteria which mainly infects the patient’s lungs. Did you know that tuberculosis (TB) has plagued humans for thousands of years, and it continues…

View Post

View Post

Lah!

EDDC Discovers Small Molecule Inhibitors For COVID-19 And Other Coronavirus Infections

August 11, 2021

These compounds target the SARS-CoV-2 main protease and are active against other coronaviruses Lead series of proprietary 3CLpro inhibitors is available for out-licensing or co-development to expedite development and make…

View Post